![]()
|
|
||||||||
J. Biol. Chem., Vol. 280, Issue 30, 27866-27871, July 29, 2005
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||







From the
The George Washington University Medical Center, Washington, D. C. 20037, the
Albert Einstein College of Medicine of Yeshiva University, Bronx, New York 10461, the ¶George Mason University, Fairfax, Virginia 22030, the ||Medical Institute of Bioregulation, Kyushu University, Fukuoka-shi 812-8582, Japan, and the **North Shore Long Island Jewish Research Institute, Manhasset, New York 11030
CD147, also known as extracellular matrix metalloproteinase inducer, is a regulator of matrix metalloproteinase production and also serves as a signaling receptor for extracellular cyclophilins. Previously, we demonstrated that cell surface expression of CD147 is sensitive to cyclophilin-binding drug cyclosporin A, suggesting involvement of a cyclophilin in the regulation of intracellular transport of CD147. In this report, we identify this cyclophilin as cyclophilin 60 (Cyp60), a distinct member of the cyclophilin family of proteins. CD147 co-immunoprecipitated with Cyp60, and confocal immunofluorescent microscopy revealed intracellular co-localization of Cyp60 and CD147. This interaction with Cyp60 involved proline 211 of CD147, which was shown previously to be critical for interaction between CD147 and another cyclophilin, cyclophilin A, in solution. Mutation of this proline residue abrogated co-immunoprecipitation of CD147 and Cyp60 and reduced surface expression of CD147 on the plasma membrane. Suppression of Cyp60 expression using RNA interference had an effect similar to that of cyclosporin A: reduction of cell surface expression of CD147. These results suggest that Cyp60 plays an important role in the translocation of CD147 to the cell surface. Therefore, Cyp60 may present a novel target for therapeutic interventions in diseases where CD147 functions as a pathogenic factor, such as cancer, human immunodeficiency virus infection, or rheumatoid arthritis.
Received for publication, April 7, 2005 , and in revised form, April 29, 2005.
* This work was supported in part by National Institutes of Health Grants R03 A1057018 and R21 A1060720 (to M. I. B.) and R01 AI029110 (to B. S.) and by funds from George Washington University. The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

To whom correspondence should be addressed: GWU Medical Center, Ross Hall Rm. 734, 2300 Eye St. N. W., Washington, D. C. 20037. Tel.: 202-994-2036; Fax: 202-994-2913; E-mail: mtmmib{at}gwumc.edu.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
This article has been cited by other articles:
![]() |
Y. Yang, N. Lu, J. Zhou, Z.-n. Chen, and P. Zhu Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis Rheumatology, September 1, 2008; 47(9): 1299 - 1310. [Abstract] [Full Text] [PDF] |
||||
![]() |
X.-L. Yu, T. Hu, J.-M. Du, J.-P. Ding, X.-M. Yang, J. Zhang, B. Yang, X. Shen, Z. Zhang, W.-D. Zhong, et al. Crystal Structure of HAb18G/CD147: IMPLICATIONS FOR IMMUNOGLOBULIN SUPERFAMILY HOMOPHILIC ADHESION J. Biol. Chem., June 27, 2008; 283(26): 18056 - 18065. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. M. Gallagher, J. J. Castorino, D. Wang, and N. J. Philp Monocarboxylate Transporter 4 Regulates Maturation and Trafficking of CD147 to the Plasma Membrane in the Metastatic Breast Cancer Cell Line MDA-MB-231 Cancer Res., May 1, 2007; 67(9): 4182 - 4189. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| All ASBMB Journals | Molecular and Cellular Proteomics |
| Journal of Lipid Research | ASBMB Today |